Author:O'Neill, Kimberly Ross, Ruby Betensky, Rebecca Billiet, Thibo Kenney, Rachel Lovett, Jessica Maletic-Savatic, Mirjana Meeks, Huong Sosa, Anna Waltz, Michael Krupp, Lauren
Session Name:S3: Multiple Sclerosis: Clinical Trials
Topic:Multiple Sclerosis
Program Number:S3.003
Author Institution:NYU Grossman School of Medicine, New York, NY Icometrix, Leuven, Belgium
Author:Amezcua, Lilyana Monson, Nancy Williams, Mitzi Reder, Anthony Wu, Gregory Vartanian, Timothy Pei, Jinglan Harp, Christopher Clayton, David Abioye, Ibraheem Bernitsas, Evanthia
Session Name:S3: Multiple Sclerosis: Clinical Trials
Topic:Multiple Sclerosis
Program Number:S3.004
Author Institution:University of Southern California, Los Angeles, CA University of Texas Southwestern, Dallas, TX Joi Life Wellness Group, SMYRNA, GA University of Chicago, Oak Park, IL Washington University, Saint Louis, MO Weill Cornell Medical College, New York, NY Genentech, Inc, South San Francisco, CA Wayne State School of Medicine, Detroit, MI
Author:Tsai, Chia-Chen Raufdeen, Fasna Schneider, Raphael Marriott, James Oh, Jiwon
Session Name:S3: Multiple Sclerosis: Clinical Trials
Topic:Multiple Sclerosis
Program Number:S3.005
Author Institution:University of British Columbia, Vancouver, BC, Canada University of Toronto, Toronto, ON, Canada
Author:Vermersch, Patrick Granziera, Cristina Mao-Draayer, Yang Cutter, Gary Kalbus, Oleksandr Staikov, Ivan Dufek, Michal Montalban, Xavier Krieger, Stephen Saubadu, Stephane Luo, Xiaodong Smyth, Brendan Djukic, Biljana Truffinet, Philippe Wallstroem, Erik Giov,
Session Name:S3: Multiple Sclerosis: Clinical Trials
Topic:Multiple Sclerosis
Program Number:S3.006
Author Institution:University of Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France , Lille, France Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland, Basel, Switzerland Autoimmunity Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA, Oklahoma City, OK Department of Biostatistics, UAB School of Public Health, Birmingham, AL, USA, Birmingham, AL Department of Neurology, Dnipro State Medical University, Dnipro, Ukraine, Dnipro, Ukraine Clinic of Neurology and Sleep Medicine, Acibadem City Clinic University Hospital Tokuda, Sofia, Bulgaria, Sofia, Bulgaria First Department of Neurology, St. Anne’s University Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic, Brno, Czech Republic Multiple Sclerosis Centre of Catalonia, Department of Neurology, Vall d'Hebron University Hospital, Barcelona, Spain , Barcelona, Spain Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York, NY, USA, New York, NY Sanofi, Gentilly, France, Gentilly, France Sanofi, Bridgewater, NJ, USA, Bridgewater, NJ Sanofi, Cambridge, MA, USA, Cambridge, MA Queen Mary University of London, London, United Kingdom , London, United Kingdom
Author:Fonseca, Elianet Olivé-Cirera, Gemma Chen, Li-Wen Paredes-Carmona, Fernando Nuñez Enamorado, Noemí Boyero Duran, Sabas Mendibe Bilbao, Maria Del Mar Visa-Reñé, Nuria Vazquez-Lopez, Maria Felipe-Rucián, Ana Romeu, Gemma Martinez-Hernandez, Eugenia M, Blanco
Session Name:S3: Multiple Sclerosis: Clinical Trials
Topic:Multiple Sclerosis
Program Number:S3.008
Author Institution:Neuroimmunology Program, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) – Caixa Research Institute, Hospital Clínic de Barcelona, Barcelona, Spain. Pediatric Neuroimmunology Unit, Neurology Department, Sant Joan de Déu Children’s Hospital, ERN-RITA reference center, University of Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Tainan, Taiwan Neurology Department, Hospital Universitario Cruces, Barakaldo, Bizkaia, Spain. Biobizkaia Health Research Institute. , Bilbao, Spain Neuroimmunology Program, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) – CaixaResearch Institute, Hospital Clínic de Barcelona, Barcelona, Spain, Barcelona, Spain Neuroimmunology Program, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) – Caixa Research Institute, Hospital Clínic de Barcelona, Barcelona, Spain, Barcelona, Spain Neuroimmunology Program, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) – Caixa Research Institute, Hospital Clínic de Barcelona, Barcelona, Spain. Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, Barcelona, Spain